Perfecting E-Prescribing

This session will provide the current status of e-prescribing including a regulatory update, identify key opportunities to improve electronic prescription accuracy, and share the results of how those opportunities are being addressed through specific initiatives targeting SIG and drug description. Additionally, the session will showcase the NCPDP SCRIPT standard-based RxChange and CancelRx transactions and the role they play in driving improved patient safety.

Learning Objectives:

  • Analyze the current state of e-prescribing adoption and utilization of e-prescribing of controlled substances
  • Review enacted and emerging state legislation intended to drive e-prescribing adoption
  • Highlight key opportunities to improve electronic prescription accuracy
  • Identify best practices using an industry wide collaboration approach to drive improvement in e-prescribing
  • Learn the progress that’s been made in electronic prescription accuracy through initiatives targeting SIG and drug description
  • Learn how the RxChange and CancelRx transactions are working to improve patient safety


  • Stacy Ward-Charlerie, PharmD, Pharmacist Data Manager, Critical Performance Improvement, Surescripts
  • Ken Whittemore, R.Ph., MBA, VP, Professional & Regulatory Affairs, Surescripts
  • Thomas Agresta, MD, MBI, Professor and Director of Medical Informatics Family Medicine, UConn Health

Sponsored by Surescripts and NCPDP